Cargando…
P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430747/ http://dx.doi.org/10.1097/01.HS9.0000848800.77383.3d |
_version_ | 1784779861322104832 |
---|---|
author | Andemariam, B. Inati, A. Colombatti, R. Minniti, C. Brown, C. Hottmann, M. Gray, S. Hoppe, C. Davis, M. Yue, P. |
author_facet | Andemariam, B. Inati, A. Colombatti, R. Minniti, C. Brown, C. Hottmann, M. Gray, S. Hoppe, C. Davis, M. Yue, P. |
author_sort | Andemariam, B. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9430747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94307472022-08-31 P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE Andemariam, B. Inati, A. Colombatti, R. Minniti, C. Brown, C. Hottmann, M. Gray, S. Hoppe, C. Davis, M. Yue, P. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430747/ http://dx.doi.org/10.1097/01.HS9.0000848800.77383.3d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Andemariam, B. Inati, A. Colombatti, R. Minniti, C. Brown, C. Hottmann, M. Gray, S. Hoppe, C. Davis, M. Yue, P. P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
title | P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
title_full | P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
title_fullStr | P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
title_full_unstemmed | P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
title_short | P1486: TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE |
title_sort | p1486: trials in progress: the thrive studies evaluating the efficacy, safety, and long-term treatment with inclacumab, a p-selectin inhibitor, in patients with sickle cell disease |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430747/ http://dx.doi.org/10.1097/01.HS9.0000848800.77383.3d |
work_keys_str_mv | AT andemariamb p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT inatia p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT colombattir p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT minnitic p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT brownc p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT hottmannm p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT grays p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT hoppec p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT davism p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease AT yuep p1486trialsinprogressthethrivestudiesevaluatingtheefficacysafetyandlongtermtreatmentwithinclacumabapselectininhibitorinpatientswithsicklecelldisease |